HCA Healthcare (NYSE:HCA) Price Target Cut to $475.00 by Analysts at KeyCorp

HCA Healthcare (NYSE:HCAGet Free Report) had its target price dropped by stock analysts at KeyCorp from $510.00 to $475.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. KeyCorp’s price objective points to a potential upside of 21.54% from the company’s previous close.

Several other equities analysts have also recently weighed in on HCA. Wall Street Zen cut HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. Jefferies Financial Group reaffirmed a “buy” rating and set a $525.00 target price on shares of HCA Healthcare in a report on Friday, April 24th. Stephens lowered their price target on shares of HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a report on Monday, April 27th. Royal Bank Of Canada decreased their target price on shares of HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating on the stock in a report on Monday, April 27th. Finally, Barclays downgraded shares of HCA Healthcare from an “overweight” rating to an “equal weight” rating and cut their price target for the company from $496.00 to $427.00 in a report on Wednesday, July 8th. Fourteen investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $495.18.

Get Our Latest Stock Report on HCA

HCA Healthcare Stock Down 3.9%

HCA opened at $390.81 on Tuesday. The company has a market capitalization of $86.70 billion, a price-to-earnings ratio of 13.44, a PEG ratio of 1.29 and a beta of 1.12. The firm has a 50-day moving average price of $396.68 and a 200-day moving average price of $459.73. HCA Healthcare has a twelve month low of $330.00 and a twelve month high of $556.52.

HCA Healthcare (NYSE:HCAGet Free Report) last released its quarterly earnings data on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). The business had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm’s quarterly revenue was up 4.3% on a year-over-year basis. During the same period last year, the business posted $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, sell-side analysts expect that HCA Healthcare will post 30.07 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Brighton Jones LLC purchased a new position in shares of HCA Healthcare during the 4th quarter valued at about $1,021,000. NewEdge Advisors LLC lifted its holdings in shares of HCA Healthcare by 11.9% in the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after acquiring an additional 409 shares during the last quarter. Sivia Capital Partners LLC grew its holdings in shares of HCA Healthcare by 5.5% during the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after purchasing an additional 33 shares during the last quarter. Jump Financial LLC bought a new stake in HCA Healthcare in the second quarter worth $2,073,000. Finally, Sei Investments Co. increased its holdings in shares of HCA Healthcare by 56.3% in the second quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock worth $52,328,000 after buying an additional 49,214 shares during the period. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

About HCA Healthcare

(Get Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Read More

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.